ESCMID

Prof. David Hayman discusses the pathogens currently on the global risk radar, the drivers of zoonotic spillover and the preparedness gaps that could shape the next pandemic. As concerns around emerging infectious diseases continue to grow, understanding the drivers of ...

Evaluating high-dose influenza vaccination strategies in older and immunocompromised populations At ESCMID Global 2026, Dr Anne Marie Reimer Jensen (Center for Translational Cardiology and Pragmatic Randomized Trials (CTCPR), Herlev and Gentofte Hospital, University of Copenhagen, Denmark) discussed findings from the FLUNITY-HD ...

As antimicrobial resistance continues to threaten global health, interest is growing in alternative approaches to treating bacterial infections. At ESCMID 2026, Dr Ikechukwu Moses presented early research exploring bacteriophages against methicillin-resistant Staphylococcus pseudintermedius, an emerging zoonotic pathogen associated with companion animals. ...

At ESCMID Global 2026, Prof. Holly Seale (University of New South Wales in Sydney, Australia) reflected on how conversations around respiratory vaccination needs to evolve, particularly for older adults. While messaging has traditionally focused on hospitalization and mortality, emerging evidence highlights ...

At ESCMID Global 2026, Prof. Holly Seale (University of New South Wales in Sydney, Australia) emphasized the importance of bringing together clinical, behavioral, and public health expertise when preparing for future respiratory threats. As innovation accelerates across vaccines, diagnostics, therapeutics, and ...

At ESCMID Global 2026, recognized as a touchINFECTIOUS DISEASES Future Leader 2026 and recipient of a Young Investigator Award, Dr Sarah Delliere (Université Paris Cité, Paris, France) discussed the growing momentum behind medical mycology and the need to rethink how invasive fungal ...

At ESCMID Global 2026, Dr Rebecca Hull (Respiratory Medicine and Gastroenterology, School of Medicine, University of Dundee, UK) discussed emerging treatment strategies for chronic Pseudomonas aeruginosa infection in bronchiectasis. In this interview, Dr Hull explains why new non-antibiotic approaches are urgently ...

At ESCMID Global 2026, Dr Clark Russell (Clinical Lecturer, Infectious Diseases & Microbiology, University of Edinburgh, Scotland, UK) discussed the growing need to rethink how bacterial infections are treated. Recognized as a touchINFECTIOUS DISEASES Future Leader 2026 and recipient of a Young ...

At ESCMID 2026, Dr Jon Salmanton-Garcia (University of Cologne, Germany) discussed the growing challenge of viral infections in immunocompromised patients. He explores how transplantation, CAR-T therapy and newer immunosuppressive treatments are changing infectious risk profiles, and highlights important advances in diagnostics, ...